Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients.
Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients.
复制标题
心脏磁共振组织追踪的全球周向应变与肥厚型心肌病患者的室性心律失常相关
DOI:
10.3389/fcvm.2021.670361
复制
发表时间:
2021
影响因子:
3.6
通讯作者:
Hu H
中科院分区:
文献类型:
--
作者:
Pu C;Fei J;Lv S;Wu Y;He C;Guo D;Mabombo PU;Chooah O;Hu H
Background: Hypertrophic cardiomyopathy (HCM) is prone to myocardial heterogeneity and fibrosis, which are the substrates of ventricular arrhythmias (VAs). Cardiac magnetic resonance tissue tracking (CMR-TT) can quantitatively reflect global and regional left ventricular strain from different directions. It is uncertain whether the change of myocardial strain detected by CMR-TT is associated with VAs. The aim of the study is to explore the differential diagnostic value of VAs in HCM by CMR-TT. Materials and Methods: We retrospectively included 93 HCM patients (38 with VAs and 55 without VAs) and 30 healthy cases. Left ventricular function, myocardial strain parameters and percentage of late gadolinium enhancement (%LGE) were evaluated. Results: Global circumferential strain (GCS) and %LGE correlated moderately (r = 0.51, P < 0.001). HCM patients with VAs had lower left ventricular ejection fraction (LVEF), global radial strain (GRS), GCS, and global longitudinal strain (GLS), but increased %LGE compared with those without VAs (P < 0.01 for all). %LGE and GCS were indicators of VAs in HCM patients by multivariate logistic regression analysis. HCM patients with %LGE >5.35% (AUC 0.81, 95% CI 0.70–0.91, P < 0.001) or GCS >-14.73% (AUC 0.79, 95% CI 0.70–0.89, P < 0.001) on CMR more frequently had VAs. %LGE + GCS were able to better identify HCM patients with VAs (AUC 0.87, 95% CI 0.79–0.95, P < 0.001). Conclusion: GCS and %LGE were independent risk indicators of VAs in HCM. GCS is expected to be a good potential predictor in identifying HCM patients with VAs, which may provide important values to improve risk stratification in HCM in clinical practice.
登录
查看更多内容
DOI:
10.1111/j.1540-8175.2011.01427.x
发表时间:
2011-08-01
影响因子:
1.5
作者:
Correia, Emanuel;Rodrigues, Bruno;Santos, Oliveira
通讯作者:
Santos, Oliveira
影响因子:
39.3
作者:
Elliott, Perry M.;Anastasakis, Aris;Watkins, Hugh
通讯作者:
Watkins, Hugh
影响因子:
5.5
作者:
Baxi, Ameya Jagdish;Restrepo, Carlos S.;Murillo, Horacio
通讯作者:
Murillo, Horacio
影响因子:
39.3
作者:
Papavassiliu, T;Schnabel, P;Borggrefe, M
通讯作者:
Borggrefe, M
影响因子:
39.3
作者:
Elliott, Perry;Andersson, Bert;Keren, Andre
通讯作者:
Keren, Andre